Akeso (HKG:9926) granted 7,115,000 share options to 114 grantees under its share option scheme at an exercise price of HK$84.60 apiece, according to a Monday filing with the Hong Kong bourse.

Chairperson Xia Yu is entitled to 3 million share options, the filing said.

The biopharmaceutical company will also offer 3,420,000 restricted share units to 107 grantees, including Xia, who will be entitled to 2 million RSUs, and six other directors.

The closing price of the shares is HK$83.15 per share, the filing said.